Lupin receives USFDA approval for generic Liraglutide Injection and Glucagon, expanding access to diabetes treatments.

Lupin has received USFDA approval for generic diabetes medications, specifically Liraglutide Injection and Glucagon for ...

Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) ...

Lupin receives US FDA approvals for liraglutide and Glucagon injectable products: Our Bureau, Mumbai Thursday, July 24, 2025, 12:20 Hrs [IST] Global pharma major Lupin Limited (Lu ...

The new implant contains a reservoir of glucagon that sits beneath the skin and can be activated in an emergency, with no need for injections. For individuals with Type 1 diabetes, the risk of ...

Pharmaceutical company Lupin has received approval from the US Food and Drug Administration (USFDA) to market generic diabetes drugs.

The US Food and Drug Administration (FDA) has instructed all GLP-1 drug-makers to update their warning labels to include the ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are overprescribing them and some patients are taking them in secret.

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

A study from Florida State University uncovers biological and behavioral consequences of weight loss underlying binge-eating in women with bulimia nervosa and related syndromes. The work is published ...

USA: A recent study published in JAMA Network Open has found that the use of glucagon-like peptide-1 (GLP-1) receptor ...

Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...